Sign In
Buy GILD
$125.05
+0.180 (+0.144%)
At Close: Jun 23, 2026
Is Gilead Sciences (GILD) Stock Outpacing Its Medical Peers This Year?
10:40am, Monday, 10'th Mar 2025
Here is how Gilead Sciences (GILD) and ANIXA BIOSCIENCES INC (ANIX) have performed compared to their sector so far this year.
Buy Gilead Sciences (GILD) Stock at 52-Week Highs?
04:55pm, Friday, 07'th Mar 2025
Medical pioneer Gilead Sciences (GILD) has seen its stock etch out new 52-week highs as the broader market pulled back sharply in recent weeks.
3 Healthcare Stocks With Strong EPS Growth Potential to Buy in 2025
09:30am, Friday, 07'th Mar 2025
GILD, OPCH and AVAH demonstrate resilience with impressive earnings surprise history.
Gilead Sciences, Inc. (GILD) Hits Fresh High: Is There Still Room to Run?
10:15am, Wednesday, 05'th Mar 2025
Gilead (GILD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Gilead Sciences, Inc. (GILD) TD Cowen 45th Annual Healthcare Conference (Transcript)
02:04pm, Tuesday, 04'th Mar 2025
Gilead Sciences, Inc. (NASDAQ:GILD ) TD Cowen 45th Annual Healthcare Conference March 4, 2025 11:10 AM ET Company Participants Johanna Mercier - Chief Commercial Officer Conference Call Participants T
Pharmaceutical Stocks Hit New Highs Amid Market Volatility
01:35pm, Tuesday, 04'th Mar 2025
During this time of heightened market volatility, it pays to be invested in the right places.
Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025
07:03am, Tuesday, 04'th Mar 2025
With the broader market facing volatility, a clutch of experts are recommending investors to look beyond mega-cap stocks like Meta, Amazon, and Netflix for opportunities in stocks with strong earnings
Gilead Sciences (GILD) Rises As Market Takes a Dip: Key Facts
06:50pm, Monday, 03'rd Mar 2025
In the closing of the recent trading day, Gilead Sciences (GILD) stood at $115.99, denoting a +1.47% change from the preceding trading day.
Gilead Sciences sets aside $200 million to resolve HIV drug probe
11:21am, Monday, 03'rd Mar 2025
Gilead Sciences set aside $200 million for a potential settlement with federal prosecutors to resolve an investigation into the drugmaker's promotional speakers program for HIV drugs.
Wall Street Bulls Look Optimistic About Gilead (GILD): Should You Buy?
10:30am, Friday, 28'th Feb 2025
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know
10:05am, Thursday, 27'th Feb 2025
Zacks.com users have recently been watching Gilead (GILD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why Gilead Sciences Remains A Buy After A 40% Rally
10:55pm, Wednesday, 26'th Feb 2025
Two weeks ago, Gilead Sciences released financial results for the fourth quarter of 2024, which exceeded even my most optimistic expectations. The strong performance of its HIV franchise was driven by
4 PEG-Based GARP Picks to Weather 2025 Market Uncertainty
12:10pm, Tuesday, 25'th Feb 2025
Here are four PEG-based GARP picks, GILD, EXEL, SYF and TAP, which qualify our screening criteria.
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Medicines Agency (EMA) has validated for parallel accelerated review the company's Marketin
Gilead Sciences: 4 Reasons This Stock Has Much More To Rise
07:16am, Saturday, 22'nd Feb 2025
Gilead Sciences Inc. NASDAQ: GILD stock surged to a new 52-week high at $106.69 recently on its fourth quarter of 2024 earnings release. After being asleep for so many years, the stock has finally fou
